Exelixis | Marketskapitalisme



Market Capitalization Endring Dato
Acadia Pharmaceuticals USD 3.05B 502M 2024-12
Agios Pharmaceuticals USD 1.87B 654M 2024-12
Amgen USD 140.1B 33.03B 2024-12
AstraZeneca GBP 162.31B 17.34B 2024-12
Bayer EUR 29.79B 3.87B 2024-09
BioMarin Pharmaceutical USD 12.53B 867M 2024-12
Bristol-Myers Squibb USD 114.71B 9.82B 2024-12
Cytokinetics USD 5.55B 661M 2024-12
Eisai JPY 1.26T 322.6B 2024-12
Eli Lilly USD 732.87B 109.15B 2024-12
Exelixis USD 9.51B 2.11B 2024-12
Genmab DKK 98.78B 8.42B 2024-12
Glaxosmithkline USD 82.81B 2.66B 2024-09
Incyte USD 13.31B 576M 2024-12
Ionis Pharmaceuticals USD 5.52B 791M 2024-12
MacroGenics USD 207M 59M 2024-09
Merck USD 251.65B 36.21B 2024-12
Moderna USD 16B 9.69B 2024-12
Neurocrine Biosciences USD 13.82B 2.18B 2024-12
Novartis CHF 194.25B 18.5B 2024-12
Pfizer USD 150.34B 13.65B 2024-12
Sanofi USD 145.36B 23.34B 2024-09
Takeda JPY 6.61T 16.72B 2024-12
Ultragenyx Pharmaceutical USD 3.88B 1.24B 2024-12
Xencor USD 1.61B 203M 2024-12



Exelixis Marketskapitalisme - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.